MedPath

A Clinical Trial to Compare the Effects of Two Oral Drugs Prednisolone and Methylprednisolone in Patients of Acute Exacerbations of COPD.

Not Applicable
Conditions
Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation
Registration Number
CTRI/2020/05/025292
Lead Sponsor
Dr Aditya Sharma
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients over 40 years of age diagnosed with A/E COPD.

Exclusion Criteria

Patients of COPD with pneumonia,

COPD with pneumothorax

Hospital stay less than 5 days,

Patient with cardiac disease,

History of asthma.

Those not giving consent.

Those unable to take oral corticosteroid.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br/ ><br>Relief in Symptoms <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 5 days
Secondary Outcome Measures
NameTimeMethod
ength of hospital stay <br/ ><br>Treatment failure <br/ ><br>Adverse effects. <br/ ><br>Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath